Clonidine as Adjunct to Morphine for Neonatal Abstinence Syndrome
Status:
Suspended
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
This is a prospective randomized double blinded study comparing the effect on duration of
pharmacologic treatment and duration of hospital stay when using clonidine at 12
µg/kilogram/day as an adjunct to oral morphine as compared to morphine monotherapy in the
management of term and near term infants with neonatal abstinence syndrome (NAS)